Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| California Walnut Commission | OTHER |
Not provided
Not provided
Not provided
Not provided
Walnuts have a unique nutritional profile, including the sleep-regulating hormone melatonin, tryptophan, and omega-3 fatty acids, the two latest nutrients involved in melatonin and serotonin synthesis. Although it has been claimed that walnuts may improve sleep, to the investigators' knowledge, no studies have been conducted to objectively determine the impact of walnut consumption on sleep and overall well-being. Therefore, this study aims to investigate the effect of daily walnut consumption on sleep parameters (such as quality and duration). Secondarily, it aims to investigate the impact of daily walnut consumption on body composition, eating behavior, and well-being.
The study to investigate the effect of daily walnut consumption on sleep quality will be conducted in an 18-week randomized crossover trial, in which participants will be initially assigned to intervention or control conditions for 8-weeks. After 2 weeks of washout, subjects will be crossed over to the alternate intervention and will continue for another 8 weeks. Note that throughout the whole study, each participant will attend 5 visits: 1 initial visit (baseline) and 2 visits in each one of the study conditions (intervention and control).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Daily walnut consumption |
|
| Control | Other | No walnut consumption |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Control | Other | Participants will be asked to refrain from walnut intake and to follow an isocaloric meal plan that complies with the recommendations of a healthy Mediterranean-style eating pattern. |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in sleep onset latency from baseline to weeks 4, 8, 14, and 18 | Measured in hours of sleep with an actigraph (ActTrust, CONDOR, Brazil) | Weeks 4, 8, 14 and 18 |
| Changes in sleep efficiency from baseline to weeks 4, 8, 14, and 18 | Calculated in percentage as the ratio of total sleep time (TST) to time in bed (TIB). Sleep efficiency (percent) = (TST/TIB)*100 | Weeks 4, 8, 14 and 18 |
| Changes in wake after sleep onset (WASO) from baseline to weeks 4, 8, 14, and 18 | Measured in minutes of WASO with an actigraph (ActTrust, CONDOR, Brazil) | Week 4, 8, 14, and 18 |
| Changes in sleep duration from baseline to weeks 4, 8, 14, and 18 | Measured in hours of sleep time with an actigraph (ActTrust, CONDOR, Brazil) | Weeks 4, 8, 14, and 18 |
| Changes in urinary 6-sulphaoxymelatonin from baseline to week 4, 8, 14 and 18 | Quantified using urine Melatonin-Sulfate ELISA kit | Week 4, 8, 14 and 18 |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in body mass index (BMI) from baseline to weeks 4, 8, 14, and 18 | Calculated as weight (kg) divided by height (in squared meters), BMI= kg/m^2 | Weeks 4, 8, 14 and 18 |
| Changes in body fat from baseline to weeks 4, 8, 14, and 18 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Maria Izquierdo-Pulido, PhD | University of Barcelona | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Torribera Campus, University of Barcelona | Santa Coloma de Gramenet | Barcelona | 08921 | Spain |
There is no plan to make IPD available.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007319 | Sleep Initiation and Maintenance Disorders |
| ID | Term |
|---|---|
| D020919 | Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Walnut intake | Other | Participants will be asked to consume walnuts along with an isocaloric meal plan that complies with the recommendations of a healthy Mediterranean-style eating pattern. |
|
Measured as the percentage of body fat with a body composition analyzer (Inbody 120, Korea)
| Weeks 4, 8, 14 and 18 |
| Changes in weight circumference from baseline to weeks 4, 8, 14, and 18 | Measured midway between the lower rib margin and the iliac crest with the subject standing and wearing only underwear, at the end of gentle expiration with an anthropometric tape (CESCORF, Brazil) | Weeks 4, 8, 14 and 18 |
| Changes in eating behavior from baseline to weeks 8 and 18 | To evaluate changes in eating behavior, the Spanish version of the Food Cravings Questionnaire will be used (Cepeda-Benito et al, 2000). This questionnaire evaluates 10 dimensions of eating behavior:
For each subscale, scores range from 0 to 5, with higher scores indicating a stronger sensation of craving. | Weeks 8 and 18 |
| Changes in well-being from baseline to weeks 8 and 18 | Well-being will be measured with the Spanish version of the WHO-5 Well-being Index (Lucas-Carrasco et. al. 2012). Scores range from 0 to 100, with higher scores indicating higher well-being. | Weeks 8 and 18 |
| D001523 |
| Mental Disorders |